Literature DB >> 12925919

Baculovirus-mediated gene expression in zebrafish.

Mahendra Wagle1, Suresh Jesuthasan.   

Abstract

In an effort to misexpress genes in zebrafish, we tested the ability of baculovirus to infect and drive gene expression in embryos. By injecting virus into specific tissues and using appropriate promoters, both the location and time of gene expression could be controlled. Using a virus with 2 different promoters, LacZ and GFP could be expressed independently. The efficiency of expression appears to depend on the promoter used. As a test of this system, baculovirus was used to ectopically express ephrinB2a in the presomitic mesoderm. EphrinB2a is normally expressed in the posterior region of developing somites, and baculovirus-mediated misexpression caused abnormal somite boundary formation. Baculovirus can thus be used as a tool for gene misexpression experiments in the zebrafish, especially when localized misexpression is required late in development.

Entities:  

Mesh:

Year:  2003        PMID: 12925919     DOI: 10.1007/s10126-002-0050-9

Source DB:  PubMed          Journal:  Mar Biotechnol (NY)        ISSN: 1436-2228            Impact factor:   3.619


  12 in total

1.  Transgene expression in Penaeus monodon cells: evaluation of recombinant baculoviral vectors with shrimp specific hybrid promoters.

Authors:  Jayesh Puthumana; Rosamma Philip; I S Bright Singh
Journal:  Cytotechnology       Date:  2015-05-17       Impact factor: 2.058

2.  Baculovirus-mediated GCRV vp7 and vp6 genes expression in silkworm and grass carp.

Authors:  Bo Liu; Yongchang Gong; Zhen Li; Xiaolong Hu; Guangli Cao; Renyu Xue; Chengliang Gong
Journal:  Mol Biol Rep       Date:  2016-04-16       Impact factor: 2.316

Review 3.  Baculovirus as versatile vectors for protein expression in insect and mammalian cells.

Authors:  Thomas A Kost; J Patrick Condreay; Donald L Jarvis
Journal:  Nat Biotechnol       Date:  2005-05       Impact factor: 54.908

Review 4.  Baculovirus as a highly efficient expression vector in insect and mammalian cells.

Authors:  Yu-chen Hu
Journal:  Acta Pharmacol Sin       Date:  2005-04       Impact factor: 6.150

5.  Characterization of the immune responses elicited by baculovirus-based vector vaccines against influenza virus hemagglutinin.

Authors:  Zhi-peng Hu; Juan Yin; Yuan-yuan Zhang; Shu-ya Jia; Zuo-jia Chen; Jiang Zhong
Journal:  Acta Pharmacol Sin       Date:  2012-05-07       Impact factor: 6.150

6.  Fast gene transfer into the adult zebrafish brain by herpes simplex virus 1 (HSV-1) and electroporation: methods and optogenetic applications.

Authors:  Ming Zou; Paul De Koninck; Rachael L Neve; Rainer W Friedrich
Journal:  Front Neural Circuits       Date:  2014-05-06       Impact factor: 3.492

7.  Highly efficient baculovirus-mediated multigene delivery in primary cells.

Authors:  Maysam Mansouri; Itxaso Bellon-Echeverria; Aurélien Rizk; Zahra Ehsaei; Chiara Cianciolo Cosentino; Catarina S Silva; Ye Xie; Frederick M Boyce; M Wayne Davis; Stephan C F Neuhauss; Verdon Taylor; Kurt Ballmer-Hofer; Imre Berger; Philipp Berger
Journal:  Nat Commun       Date:  2016-05-04       Impact factor: 14.919

8.  Topoisomerase II Inhibitors Can Enhance Baculovirus-Mediated Gene Expression in Mammalian Cells through the DNA Damage Response.

Authors:  Ming-Kun Liu; Jhe-Jhih Lin; Chung-Yung Chen; Szu-Cheng Kuo; Yu-Ming Wang; Hong-Lin Chan; Tzong Yuan Wu
Journal:  Int J Mol Sci       Date:  2016-06-14       Impact factor: 5.923

9.  Highly efficient transduction of primary adult CNS and PNS neurons.

Authors:  Evgeny Levin; Heike Diekmann; Dietmar Fischer
Journal:  Sci Rep       Date:  2016-12-13       Impact factor: 4.379

Review 10.  Antigen delivery systems for veterinary vaccine development. Viral-vector based delivery systems.

Authors:  Alejandro Brun; Emmanuel Albina; Tom Barret; David A G Chapman; Markus Czub; Linda K Dixon; Günther M Keil; Bernard Klonjkowski; Marie-Frédérique Le Potier; Geneviève Libeau; Javier Ortego; Jennifer Richardson; Haru-H Takamatsu
Journal:  Vaccine       Date:  2008-12-02       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.